APA (7th ed.) Citation

Noske, A., Ammann, J., Wagner, D., Denkert, C., Lebeau, A., Sinn, P., . . . Weichert, W. (2019). 359P - Reproducibility and concordance of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays in triple negative breast cancer (TNBC). Annals of Oncology, 30, v130. https://doi.org/10.1093/annonc/mdz242.054

Chicago Style (17th ed.) Citation

Noske, A., et al. "359P - Reproducibility and Concordance of 4 Clinically Developed Programmed Death-ligand 1 (PD-L1) Immunohistochemistry (IHC) Assays in Triple Negative Breast Cancer (TNBC)." Annals of Oncology 30 (2019): v130. https://doi.org/10.1093/annonc/mdz242.054.

MLA (9th ed.) Citation

Noske, A., et al. "359P - Reproducibility and Concordance of 4 Clinically Developed Programmed Death-ligand 1 (PD-L1) Immunohistochemistry (IHC) Assays in Triple Negative Breast Cancer (TNBC)." Annals of Oncology, vol. 30, 2019, p. v130, https://doi.org/10.1093/annonc/mdz242.054.